Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology

Salman, AndaçAlper, SibelAtakan, NilgünBorlu, MuratCanpolat, FilizErdem, TeomanErdem, YaseminGül, ÜlkerKartal, Selda PelinKoca, RafetKüçük, Özlem Su2023-11-022023-11-022020-12Salman, A. vd. (2020). "Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology". Turkderm Turkish Archives of Dermatology and Venereology, 54(2), 71-75.2717-63982651-5164https://doi.org/10.4274/turkderm.galenos.2020.80000https://jag.journalagent.com/turkderm/pdfs/TURKDERM_54_2_71_75.pdfhttp://hdl.handle.net/11452/34757eninfo:eu-repo/semantics/openAccessDermatologyAtopic dermatitisCovid-19TreatmentUrticariaOmalizumabMetaanalysisAtopik dermatitCOVID-19DupilumabTedaviÜrtikerRecommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of DermatologyCOVID-19 pandemisi süresince ürtiker ve atopik dermatitte sistemik tedavilerin kullanımına ilişkin öneriler: Türk Dermatoloji Derneği dermatoallerji çalışma grubu bildirisiLetter0005444096000082-s2.0-850899134487175542DermatologySkin; Allergic contact dermatitis; COVID-19AzathioprineCyclosporineDupilumabInterleukin 1betaInterleukin 6MethotrexateMycophenolate mofetilOmalizumabPrednisoloneAtopic dermatitisCoronavirus disease 2019Cytokine stormHumanHypertensionImmunosuppressive treatmentImmunotherapyInflammationLetterObesityPandemicRandomized controlled trial (topic)Risk factorSevere acute respiratory syndrome coronavirus 2Shared decision makingSystemic therapyUrticaria